Home

Seed to Series C

A new kind of business building event is coming. Learn more
Scroll to main body

Our Impact

211 Projects Projects
59 Spinouts Spinouts
$22M Granted

Projects

Glycan-binding nanobodies: A platform for diagnostics and therapeutics

This team is developing nanobody-based glycan-binding proteins that focus on a specific antigen prominent in cancer research and therapeutics.

Spinouts

InSpek

Raman-on-a-chip sensors for real time biological and chemical monitoring.